drugset
drugset / Trial / NCT01689194

Efficacy Study of Genexol-PM and Cisplatin in Locally Advanced Head and Neck Cancer

NCT01689194 ↗

Phase 2 Completed 53 enrolled Seoul National University Hospital Clinical Research Center for Solid Tumor, Korea · collab
NaSingle-groupOpen-labelTreatment

Summary

This clinical trial is Phase II trial for evaluating efficacy of induction chemotherapy using Genexol-PM + cisplatin for locally advanced head and neck cancer. The investigators try to evaluate response rate of Genexol-PM + cisplatin chemotherapy, and safety profile.

Timeline

Start
2013-02
Primary completion
2016-04
Completion
2017-08-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 30 mg/m2 —
Subject Cisplatin Other / unclassified 60 mg/m2 —
Subject Paclitaxel Small molecule 230 mg/m2 —

Indications

head and neck squamous cell carcinoma